Thousand Oaks, CA, United States of America

Devrishi Goswami

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):

Title: Devrishi Goswami: Innovator in Pharmaceutical Composition

Introduction

Devrishi Goswami is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance the storage and administration of bispecific antibody constructs.

Latest Patents

Goswami holds a patent for a pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration. This invention provides an improved pharmaceutical composition that includes a bispecific antibody construct, a preservative, and a diluent, ensuring that the bispecific antibody construct remains stable and recoverable. His patent is particularly valuable as it addresses the challenges associated with the storage and administration of these complex biological molecules. He has 1 patent to his name.

Career Highlights

Devrishi Goswami is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Amgen has allowed him to focus on developing advanced pharmaceutical solutions that can significantly impact patient care.

Collaborations

Throughout his career, Goswami has collaborated with esteemed colleagues, including Jeff Abel and Lingwen Cui. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical technologies.

Conclusion

Devrishi Goswami is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to bispecific antibody constructs. His work continues to influence the field, paving the way for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…